IDG-Accel China Growth Fund III Associates’s Aesthetic Medical International Holdings AIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$1.51M Sell
369,867
-42,601
-10% -$210K 4.83% 6
2021
Q2
$3.28M Sell
412,468
-521,332
-56% -$3.89M 5.97% 6
2021
Q1
$6.87M Hold
933,800
9.27% 4
2020
Q4
$4.92M Hold
933,800
5.69% 4
2020
Q3
$3.98M Hold
933,800
7.24% 6
2020
Q2
$5.77M Hold
933,800
4.74% 6
2020
Q1
$8.47M Hold
933,800
4.48% 6
2019
Q4
$6M Buy
+933,800
New +$6.75M 2.14% 6

Other funds holding AIH

IDG-Accel China Growth Fund III Associates's AIH Position: Q3 2021 in Review

IDG-Accel China Growth Fund III Associates reduced its Aesthetic Medical International Holdings (AIH) stake by 10% in Q3 2021, selling an estimated $210K and leaving 369,867 shares worth $1.51M. The position accounts for 4.83% of the portfolio, ranked #6.

IDG-Accel China Growth Fund III Associates first reported a position in AIH in Q4 2019 and has held it in 8 quarters since. The position peaked at $8.47M in Q1 2020. 6 funds tracked by Wall St. Rank hold AIH as of Q3 2021.

  • IDG-Accel China Growth Fund III Associates held 369,867 shares of Aesthetic Medical International Holdings worth $1.51M as of Q3 2021.
  • IDG-Accel China Growth Fund III Associates sold 42,601 Aesthetic Medical International Holdings shares in Q3 2021, an estimated $210K.
  • Aesthetic Medical International Holdings made up 4.83% of IDG-Accel China Growth Fund III Associates's portfolio in Q3 2021, its #6 holding.
  • IDG-Accel China Growth Fund III Associates first reported a position in Aesthetic Medical International Holdings in Q4 2019 and has held it in 8 quarters since.
  • IDG-Accel China Growth Fund III Associates's Aesthetic Medical International Holdings position peaked at $8.47M in Q1 2020.
  • 6 funds tracked by Wall St. Rank held Aesthetic Medical International Holdings as of Q3 2021.

Based on IDG-Accel China Growth Fund III Associates's 13F filing for Q3 2021, filed 15 Nov 2021.